NCT03756636

Brief Summary

All procedures are performed in the investigator's outpatient gastroenterology and digestive endoscopy unit by experienced endoscopists in conventional mucosectomies of the lower intestinal tract. Before the procedure each patient, a normal endoscopic procedure. At the site of the lesion the lumen will be completely decompressed with aspiration of the gas, and then again relaxed with the instillation of only water. The EleviewTM will be injected into the submucosa in such quantities as to obtain a satisfactory lift of the lesion. The lesion will then be removed with a diathermic loop, preferably en-bloc, and in any case up to macroscopic evidence of complete resection. All the removed material will be stored and sent to histological analysis. Tolerability score will be recorded during the procedure. Any "bleeding" (both intra- and post-procedural), perforation, post-polypectomy syndrome, stenosis or death in the 6 months following the procedure will be born "complication". A surveillance colonoscopy including biopsy sampling of the research site scheduled 6 months after the procedure

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 26, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 28, 2018

Completed
Last Updated

January 13, 2020

Status Verified

September 1, 2019

Enrollment Period

6 months

First QC Date

November 26, 2018

Last Update Submit

January 10, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Macroscopically complete resection rate

    6 Months

  • 6-month recurrence rate;

    6 Months

  • Rate of adverse events (according to the lexiconA ASGE).

    6 Months

Study Arms (1)

"Underwater" mucosectomy

OTHER

"Underwater" mucosectomy with submucosal injection of viscous solution -SIC 8000 (EleviewTM)

Procedure: "Underwater" mucosectomy with submucosal injection of viscous solution -SIC 8000 (EleviewTM)

Interventions

"Underwater" mucosectomy with submucosal injection of viscous solution -SIC 8000 (EleviewTM)

"Underwater" mucosectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\> 18 years.
  • Signing of informed consent.
  • Possibility of being subjected to the diagnostic and therapeutic procedures of the study.
  • Presence of colo-rectal polypoid lesions ≥ 15mm presenting macroscopic aspects of fibrosis as a consequence of previous incomplete treatments or biopsies or relapses after previous removal.

You may not qualify if:

  • Highly indicative morphological characteristics of carcinoma with submucosal invasion (Ulceration, Pit Pattern Vn according to Kudo et al.18)
  • Pregnancy or breastfeeding
  • ASA\> 3
  • Unstable personality or unable to adhere to the protocol procedures.
  • Inability to provide informed consent.
  • Injury not reachable endoscopically.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endoscopy Unit, Gastroenterology Department, Humanitas Research Hospital

Rozzano, Milano, 20089, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2018

First Posted

November 28, 2018

Study Start

June 1, 2018

Primary Completion

November 26, 2018

Study Completion

November 26, 2018

Last Updated

January 13, 2020

Record last verified: 2019-09

Locations